Extracted from this filing and checked against the source text.
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
VOLITIONRX LTD issued convertible note to Lind Global Asset Management XII LLC for principal amount of $2,400,000.
- Security
- convertible note
- Purchaser
- Lind Global Asset Management XII LLC
- Consideration
- principal amount of $2,400,000
Exact text from the filing
we will receive $2,000,000 in funding from Lind in exchange for the issuance to Lind of a Senior Secured Convertible Promissory Note in the principal amount of $2,400,000
View on SEC.gov
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
VOLITIONRX LTD issued 7,000,350 shares of warrant to Lind Global Asset Management XII LLC for $0.5714 per share.
- Security
- warrant
- Shares
- 7,000,350 shares
- Purchaser
- Lind Global Asset Management XII LLC
- Consideration
- $0.5714 per share
Exact text from the filing
a Common Stock Purchase Warrant for the purchase of 7,000,350 shares of our common stock at a price of $0.5714 per share
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
VOLITIONRX LTD amended Amended SPA with Lind Global Asset Management XII LLC valued at $2,000,000 (effective 2026-01-07).
- Action
- amendment
- Agreement
- equity purchase
- Counterparty
- Lind Global Asset Management XII LLC
- Value
- $2,000,000
- Effective
- 2026-01-07
Exact text from the filing
On January 7, 2026, VolitionRx Limited (the “Company”) entered into an amended and restated securities purchase agreement (the “Amended SPA”) with Lind Global Asset Management XII LLC, a Delaware limited liability company (“Lind”). Under the Amended SPA, within ten business days of signing, and subject to the satisfaction of certain closing conditions, we will receive $2,000,000 in funding from Lind
View on SEC.gov